Skip to main content

Published

COVID-19 vaccine effectiveness in people on immunosuppressive therapies: a systematic review and meta-analysis.
Stadler E. The Lancet Microbe 2026;:https://doi.org/10.1016/j.lanmic.2026.101424.
[A systematic review of 35 studies found COVID-19 vaccination substantially benefits people receiving immunosuppressive therapies. After three doses, effectiveness was 82% against pre-Omicron infection and 88% against hospitalisation. However, compared with vaccinated healthy people, immunosuppressed patients remained at greater risk of infection, hospitalisation and death. Findings support continued vaccination and further research on updated boosters.]
Freely available online

Age Groups
Adults
Conditions and Lifestyle Factors
Coronavirus Infections
Settings
Staff Groups
Immunisation
Medic / Dentist